Search

link to homepage

Central Institute for Engineering, Electronics and Analytics (ZEA)
(leer)

Navigation and service


BrainMet -Bioimaging of Metals in Brain and Metallomics

a novel and powerful technology fo future dementia research

BrainMet (Brainmet - Bioimaging of Metals in Brain and Metallomics) was inaugurated on 9 December 2009 as an innovative and powerful technology for dementia research. The analytical BrainMet centre of excellence at the Analytik (ZEA-3) of Forschungszentrum Jülich was founded with expertise and equipment from Thermo Scientific, in cooperation with associates from the medical institutes at Forschungszentrum Jülich, and with partners from Europe and America. The cutting-edge analytical BrainMet technology now available enables assays to be performed concerning the specific quantitative distribution of metals in tissue sections (bioimaging) combined with investigations on the binding of metals to proteins (metallomics) for brain research.

BrainMet-LogoBrainMet-Logo


Servicemeu

Homepage

Logo

 

 

 

YOUR OPINION MATTERS!

 

Dear visitor,

To make our website suit your needs even more and to give it a more appealing design, we would like you to answer a few short questions.

Answering these questions will take approx. 10 min.

Start now Close window

Thank you for your support!

 

In case you have already taken part in our survey or in case you have no time to take part now, you can simply close the window by clicking "close".

If you have any questions on the survey, please do not hesitate to contact: webumfrage@fz-juelich.de.

 

Your Team at Forschungszentrum Jülich

 

Note: Forschungszentrum Jülich works with the market research institute SKOPOS to anonymously conduct and analyze the survey. SKOPOS complies with the statutory requirements on data protection as well as with the regulations of ADM (Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V.) and ESOMAR (Europäische Gesellschaft für Meinungs- und Marketingforschung). Your data will not be forwarded to third parties.